Endogenous inhibitors of hypertrophy in concentric versus eccentric hypertrophy

European Journal of Heart Failure

Volumn 9, Issue 4, 2007, Pages 352-356

  Lemmens, Katrien ^a   Segers, Vincent F M ^a   Demolder, Marc ^a   Michiels, Maria ^a   Van Cauwelaert, Philip ^b   De Keulenaer, Gilles W ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b MIDDELHEIM HOSPITAL   (Belgium)

Author keywords

gene expression; heart failure; Hypertrophy; redox

Indexed keywords

MESSENGER RNA; PROTEIN; PROTEIN MCIP 1; PROTEIN VDUP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; AORTA STENOSIS; ARTICLE; DISEASE COURSE; GENE EXPRESSION; HEART LEFT VENTRICLE HYPERTROPHY; HEMODYNAMICS; MALE; MITRAL VALVE REGURGITATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; AORTIC VALVE STENOSIS; DISEASE PROGRESSION; GENE EXPRESSION; HEART FAILURE, CONGESTIVE; HYPERTROPHY, LEFT VENTRICULAR; MALE; MITRAL VALVE INSUFFICIENCY; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33947313322     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2006.10.002     Document Type: Article

References (20)

1. Frey N., Katus H.A., Olson E.N., and Hill J.A. Hypertrophy of the heart: a new therapeutic target?. Circulation 109 (2004) 1580-1589
2. Drazner M.H. The transition from hypertrophy to failure: how certain are we?. Circulation 112 (2005) 936-938
3. Yamamoto K., Dang Q.N., Maeda Y., Huang H., Kelly R.A., and Lee R.T. Regulation of cardiomyocyte mechanotransduction by the cardiac cycle. Circulation 103 (2001) 1459-1464
4. Dorn II G.W. Physiologic growth and pathologic genes in cardiac development and cardiomyopathy. Trends Cardiovasc Med 15 (2005) 185-189
5. Hoshijima M., and Chien K.R. Mixed signals in heart failure: cancer rules. J Clin Invest 109 (2002) 849-855
6. Pan J., Fukuda K., Saito M., Matsuzaki J., Kodama H., Sano M., Takahashi T., Kato T., and Ogawa S. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circ Res 84 (1999) 1127-1136
7. Wang Y., De Keulenaer G.W., and Lee R.T. Vitamin D(3)-up-regulated protein-1 is a stress-responsive gene that regulates cardiomyocyte viability through interaction with thioredoxin. J Biol Chem 277 (2002) 26496-26500
8. De Keulenaer G.W., Wang Y., Feng Y., Muangman S., Yamamoto K., Thompson J.F., Turi T.G., Landschutz K., and Lee R.T. Identification of IEX-1 as a biomechanically controlled nuclear factor-kappaB target gene that inhibits cardiomyocyte hypertrophy. Circ Res 90 (2002) 690-696
9. Hardt S.E., and Sadoshima J. Negative regulators of cardiac hypertrophy. Cardiovasc Res 63 (2004) 500-509
10. Yasukawa H., Hoshijima M., Gu Y., Nakamura T., Pradervand S., Hanada T., et al. Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways. J Clin Invest 108 (2001) 1459-1467
11. Wang Y., De Keulenaer G.W., Weinberg E.O., Muangman S., Gualberto A., Landschulz K.T., et al. Direct biomechanical induction of endogenous calcineurin inhibitor Down Syndrome Critical Region-1 in cardiac myocytes. Am J Physiol Heart Circ Physiol 283 (2002) H533-H539
12. Bueno O.F., De Windt L.J., Lim H.W., Tymitz K.M., Witt S.A., Kimball T.R., et al. The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo. Circ Res 88 (2001) 88-96
13. Rothermel B.A., McKinsey T.A., Vega R.B., Nicol R.L., Mammen P., Yang J., et al. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A 98 (2001) 3328-3333
14. Coucelo J., Joaquim N., and Coucelo J. Calculation of volumes and systolic indices of heart ventricle from Halobatrachus didactylus: echocardiographic noninvasive method. J Exp Zool 286 (2000) 585-595
15. Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57 (1986) 450-458
16. Teichholz L.E., Kreulen T., Herman M.V., and Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 37 (1976) 7-11
17. Takano H., Zou Y., Akazawa H., Toko H., Mizukami M., Hasegawa H., et al. Inhibitory molecules in signal transduction pathways of cardiac hypertrophy. Hypertens Res 25 (2002) 491-498
18. Rothermel B.A., Berenji K., Tannous P., Kutschke W., Dey A., Nolan B., et al. Differential activation of stress-response signaling in load-induced cardiac hypertrophy and failure. Physiol Genomics 23 (2005) 18-27
19. Haq S., Choukroun G., Lim H., Tymitz K.M., del Monte F., Gwathmey J., et al. Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation 103 (2001) 670-677
20. Yoshioka J., Schulze P.C., Cupesi M., Sylvan J.D., MacGillivray C., Gannon J., et al. Thioredoxin-interacting protein controls cardiac hypertrophy through regulation of thioredoxin activity. Circulation 109 (2004) 2581-2586